Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study

BACKGROUND: To assess acute (primary endpoint) and late toxicity, quality of life (QOL), biochemical or clinical failure (secondary endpoints) of a hypofractionated IMRT schedule for prostate cancer (PC). METHODS: 38 men with localized PC received 66 Gy (2.64 Gy) to prostate,2 Gy to seminal vesicles...

Descripción completa

Detalles Bibliográficos
Autores principales: Junius, Sara, Haustermans, Karin, Bussels, Barbara, Oyen, Raymond, Vanstraelen, Bianca, Depuydt, Tom, Verstraete, Jan, Joniau, Steven, Van Poppel, Hendrik
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971267/
https://www.ncbi.nlm.nih.gov/pubmed/17686162
http://dx.doi.org/10.1186/1748-717X-2-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971267/
https://www.ncbi.nlm.nih.gov/pubmed/17686162
http://dx.doi.org/10.1186/1748-717X-2-29

Ejemplares similares